Ahmed earned his BVSc and Master’s degree in veterinary microbiology from Zagazig University's Faculty of Veterinary Medicine in Egypt, followed by a PhD at Cairo University's Faculty of Veterinary Medicine, where he collaborated with Japan's National Institute of Animal Health (NIAH). His research focused on studying how avian cytokine genes respond to infection and vaccination with different strains of highly pathogenic avian influenza H5N1 viruses. After completing his PhD, Ahmed joined the WOAH reference laboratory of infectious bursal disease virus (IBDV), VIPAC, Anses, France, as a postdoc. There, he concentrated on the genetic, antigenic, and pathogenic characterization of newly emerged strains of IBDV and share in developing reverse genetic systems. At the Egyptian Reference Laboratory for Veterinary Quality Control, Ahmed contributed to a team working on developing and evaluating reverse genetic-based vaccines for circulating avian viral diseases. Later, Ahmed joined The Pirbright Institute as a postdoc, where he focused on generating cell lines with ablated chIFITM expression using CRISPR/Cas9 technology. These cell lines are crucial for testing against various avian pathogens to enhance vaccine yields. Currently, Ahmed serves as a Pirbright Institute fellow, leading efforts to establish a research program focused on studying IBDV that pose a significant threat to global poultry production mainly due to their immunosuppressive effects on young chickens, which worsen secondary infections and reduce the efficacy of other viral vaccines.